MicroMed Cardiovascular, Inc. (OTC: MMCV)
MicroMed Cardiovascular, Inc. has developed promising ventricular assist device (VAD) technologies for the treatment of congestive heart failure (CHF), a disease that afflicts 15 million people worldwide and five million in the U.S. More than 550,000 new cases of CHF are diagnosed each year.
Heart transplantation is traditionally the only treatment hope for most late-stage CHF patients. Due to the lack of donor hearts, there are only 2,500 heart transplants performed each year in the United States and a similar number occur in Europe. While patients with this progressive disease are still treated with drug therapy, a VAD can be critical to their saving life while they wait for a donor heart.
MicroMed intends to provide a reliable, lower cost, miniaturized VAD. The MicroMed DeBakey VADR is initially targeted for Class IV, end-stage heart failure patients as a "bridge to cardiac transplant".
In the near future, MicroMed believes that VADs have the potential to be used as Destination Therapy, Acute Myocardial Infarction, and to bridge to recovery. There are in excess of 300,000 patients that can use the DeBakey VADR in these four indications. What is exciting in this fourth indication is the opportunity for growth factors or drugs such as "cleubuterol" to stimulate regrowth for the heart as the pump provides the rest and assistance.
| Company | MicroMed Cardiovascular, Inc. |
|---|---|
| URL | http://www.micromedtech.com/ |
Houston, June 12, 2007 - MicroMed Cardiovascular, Inc., (OTCBB: MMCV) (www.micromedcv.com), a ventricular assistance device company, today announced that it has elected Pamela Westbrook to its...
HOUSTON (May 1, 2007) - MicroMed Cardiovascular, Inc. (OTCBB:MMCV) Board of Directors have announced their unanimous approval of Mr. Robert (Bob) Benkowski as the new Chief Executive Officer for the Corporation replacing interim CEO Clifford ...
HOUSTON (February 13, 2007) - MicroMed Cardiovascular, Inc. (OTCBB:MMCV) is a proud sponsor of The Methodist Hospital Left Ventricular Assist Device Program in Houston, Texas.
HOUSTON--(BUSINESS WIRE)--July 21, 2006--MicroMed Cardiovascular, Inc. (OTCBB:MMCV - News) is pleased to announce that Professor Erwin P. Bauer, MD and Mr. Clifford zur Nieden have joined the company's board of directors.
MicroMed Announces Hiring Of Alan Totah As Senior Vice President Of Regulatory Affairs And Quality Systems
HOUSTON (July 12, 2006) - MicroMed Cardiovascular, Inc. (OTCBB: MMCV) is pleased to announce that Alan Totah has joined the company as Senior Vice President, Regulatory Affairs and Quality Systems. Mr. Totah previously served as Vice Presiden...
HOUSTON (June 19, 2006) - MicroMed Cardiovascular, Inc. (OTCBB:MMCV) is pleased to announce that it has completed an equity financing through a private placement of $15.425 million of its common stock and warrants to purchase its common stock ...
MicroMed Announces Post Market European Evaluation Of The Latest Design Of DeBakey VAD(R)
HOUSTON (March 17, 2006) - MicroMed Cardiovascular, Inc. (OTC BB: MMCV), a medical device company focused on the development of miniaturized implantable ventricular assist technology, announced today that it has initiated a multicenter evaluat...
MicroMed Announces Closing Of Financing
HOUSTON (December 2, 2005) - MicroMed Cardiovascular, Inc. (OTCBB:MMCV) is pleased to announce that it has completed an equity financing through a private placement of $5.15 million of its common stock by Hunter World Markets, Inc. of Beverly ...
MicroMed Announces Closing Of Financing
Today we learned that the OTC Bulletin Board (OTCBB) mistakenly believed we were delinquent with our Form 10-QSB filing. In the mistaken belief that we were delinquent in this required filing,...
HOUSTON--(BUSINESS WIRE)--Oct. 4, 2005--MicroMed Cardiovascular, Inc. (OTCBB:MMCV), a leader in miniaturized implantable ventricular assist technology, announced today that it has retained CCG to plan and conduct a program of investor relation...
MicroMed DeBakey VAD, First Miniaturized Heart Pump Implanted for Long-Term CHF Therapy
HOUSTON--(BUSINESS WIRE)--Nov. 11, 2004--MicroMed Technology Inc., a world leader in miniaturized implantable ventricular assist techhnology, announced today that it has implanted the first DeBakey VADR (ventricular assist device) for Des...
MicroMed DeBakey VAD, First Miniaturized Heart Pump Implanted for Long-Term CHF Therapy
HOUSTON (October 6, 2004) - MicroMed Technology, Inc., global leader in miniaturized heart pump technology, applauds the recent announcement by the Centers for Medicare & Medicaid Services (CMS) increasing reimbursement for all Ventricular Ass...
The First Miniaturized Heart Pump for Children Approved
HOUSTON -- March 3, 2004 - MicroMed Technology, Inc., a global leader in miniaturized heart pump technology, announced today that it has received Food & Drug Administration (FDA) Humanitarian Device Exemption (HDE) approval to provide transpla...
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
11/01/2007 | Nobuhiro Shimizu【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
07/18/2007 | Taro InabaMitsui Ventures Launching a New Approach to Seed Financing